澄星股份(600078) - 2025 Q2 - 季度业绩预告

Jiangsu Chengxing Phosph-Chemical Co., Ltd. 2025 Semi-Annual Performance Forecast Current Period Performance Forecast The company forecasts a turnaround to profitability in the first half of 2025, with net profit attributable to shareholders expected to range from RMB 16 million to RMB 23 million, though non-recurring net profit remains a loss, and these figures are unaudited | Indicator | Estimated Amount (RMB) | | :--- | :--- | | Performance Forecast Period | January 1, 2025 to June 30, 2025 | | Net Profit | RMB 44 million to RMB 65 million | | Net Profit Attributable to Parent Company Shareholders | RMB 16 million to RMB 23 million (Turnaround to Profit) | | Net Profit Attributable to Parent Company Shareholders (Excluding Non-Recurring Items) | -RMB 36 million to -RMB 27 million | - The performance forecast data for this period has not been audited by a certified public accountant[4] Operating Performance and Financial Status in the Same Period Last Year In the first half of 2024, the company incurred losses, with net profit attributable to parent company shareholders at -RMB 16.71 million and net loss after deducting non-recurring items at -RMB 48.55 million | Indicator (H1 2024) | Amount (RMB) | | :--- | :--- | | Total Profit | -RMB 5.42 million | | Net Profit Attributable to Parent Company Shareholders | -RMB 16.71 million | | Net Profit Attributable to Parent Company Shareholders (Excluding Non-Recurring Items) | -RMB 48.55 million | | Earnings Per Share | -RMB 0.025/share | Primary Reasons for Turning Losses into Profits in the Current Period The company's turnaround to profitability is primarily attributed to optimizing production and sales strategies for yellow phosphorus and phosphoric acid, advancing lean management to control costs, disposing of idle assets to recover funds, and reducing interest expenses through debt repayment - Optimized production and sales strategies in response to yellow phosphorus market conditions, increasing sales of yellow phosphorus and phosphoric acid, leading to year-over-year growth in sales revenue and increased market share[7] - Continuously advanced lean management, effectively reducing raw material, energy consumption, and procurement operating costs[7] - Disposed of and revitalized idle assets to recover funds, prioritizing debt principal repayment, which led to a year-over-year decrease in interest expenses[7] Risk Warning The company explicitly states that this performance forecast is a preliminary calculation by the finance department based on current operations and has not been audited by a certified public accountant, thus its accuracy is subject to uncertainty - This performance forecast represents preliminary calculations by the company's finance department and has not yet been audited by a certified public accountant[8] - The company declares no significant uncertainties exist that would affect the accuracy of this performance forecast[8] Other Explanatory Notes The company reminds investors that the disclosed data is preliminary, and the final accurate financial figures will be based on the officially released 2025 semi-annual report, urging investors to be aware of investment risks - Final financial data will be subject to the company's officially disclosed 2025 semi-annual report, and investors are advised to be aware of investment risks[9]